NIH plans to slash support for indirect research costs, sending shockwaves through science
The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15%
Related Articles
The dark zone of CNS relapse in DLBCL
In this issue of Blood, Alduaij and colleagues report on central nervous system (CNS) relapse rates in a retrospective cohort of patients with high-grade B
LungMAP – Home
We are extremely grateful to the families who have generously given such precious gifts to support this important research.
Class action suit over UnitedHealth’s AI care denials nears key moment
A ruling may come this month on UnitedHealth’s motion to dismiss a lawsuit stemming from STAT reporting on the firm’s use of AI to cut…
The User’s Guide to Amivantamab
Targeted Oncology – Targeted therapies have revolutionized treatment of non-small-cell lung cancer (NSCLC); however, epidermal growth factor receptor (EGFR) exon20ins mutations are resistant to…
Opinion | Now Will We Believe What Is Happening Right Before Our Eyes?
There can be no appeasement. None.
NIH plans to slash support for indirect research costs, sending shockwaves through science
The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15%
NIH plans to slash support for indirect research costs, sending shockwaves through science
The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15%
NIH plans to slash support for indirect research costs, sending shockwaves through science
The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15%
NIH plans to slash support for indirect research costs, sending shockwaves through science
The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15%
Health Rounds: Vaccine keeps advanced kidney cancer from recurring
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small early-stage trial,…
